• Population-level screening design, implementation, and evaluation dominate this era, comparing universal versus selective screening, invitation strategies, and cohort outcomes to gauge impact on cervical cancer prevention [4], [12], [10], [14], [16], [13].

• Etiology and risk framing center on sexual transmission, partner effects, and gynecologic risk factors, influencing screening recommendations and prevention emphasis [2], [3], [20], [11], [19].

• Cytology-focused screening methodology and technology: development and evaluation of prescreening, cytology accuracy, defining target populations, and histological correlations [17], [18], [15], [9], [14], [16], [13].

• Age- and youth-focused research agenda examines disease prevalence and screening implications for younger women, guiding age-specific screening strategies [7], [15], [16], [9].

• Population-based incidence and socio-demographic patterns, including marital status and regional trends, inform risk stratification and surveillance [20], [6], [5].